MIRM
Mirum Pharmaceuticals Inc Earnings
$68.51
Earnings Summary
Revenue | $133.01Mn |
Net Profits | $2.91Mn |
Net Profit Margins | 2.18% |
Mirum Pharmaceuticals Inc’s revenue jumped 47.17% since last year same period to $133.01Mn in the Q3 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 4.09% jump in its revenue since last 3-months.
Mirum Pharmaceuticals Inc’s net profit jumped 120.41% since last year same period to $2.91Mn in the Q3 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 149.56% jump in its net profits since last 3-months.
Mirum Pharmaceuticals Inc’s net profit margin jumped 113.87% since last year same period to 2.18% in the Q3 2025. On a quarterly growth basis, Mirum Pharmaceuticals Inc has generated 147.62% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Current Year | -0.19 |
Mirum Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.19 - a 41.76% jump from last quarter’s estimates.
Mirum Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.19.
Key Ratios
Earning Per Share (EPS) | 0 |
Mirum Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Mirum Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-07 | -0.48 | -0.3 | 37.5% |
2025-08-06 | -0.33 | -0.12 | 63.64% |
2025-11-04 | -0.19 | 0 | 100% |
